Literature DB >> 19767788

Taste disorders and oral evaluation in patients undergoing allogeneic hematopoietic SCT.

C C Boer1, M E P Correa, E C M Miranda, C A de Souza.   

Abstract

The aim of this study was to evaluate taste perception, salivary flow rate and oral pathologies in three different groups of patients undergoing hematopoietic SCT (HSCT) classified according to time post transplant. Group I (n=20) up to 150 days after HSCT, group II (n=20) between 151 and 1095 days and group III (n=21) more than 1095 days. Taste acuity was measured by four basic tastes of four solutions, in three concentrations (M): NaCl, sucrose, citric acid and caffeine. Patients classified flavors as sweet, sour, salty, bitter and without flavor. The intensity was considered high, medium and low. Unstimulated saliva was collected and salivary flow rates (ml/min) were determined. Of 61 patients, 31 had chronic GVHD. For the sweet solution, the high and low concentrations represented a challenge for those patients. No patients were sensitive to the low concentration of caffeine solution (P=0.05). Saliva flow rate was diminished in 10 of 61 (16%) patients and hyposalivation was more intense in groups II/III (P=0.007). There was no correlation between taste dysfunction and oral chronic GVHD. The results indicated taste alterations only for the sweet and salty tastes even in patients up to 3 years after HSCT and may not correlate with oral chronic GVHD and with hyposalivation.

Entities:  

Mesh:

Year:  2009        PMID: 19767788     DOI: 10.1038/bmt.2009.237

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  16 in total

1.  The experience of dysgeusia in allogeneic haematopoietic cell transplantation survivors: a qualitative study.

Authors:  Davide Bomben; Alessandra Bin; Margherita Venturini; Teresa Bulfone; Luca Ghirotto; Valentina Bressan
Journal:  Support Care Cancer       Date:  2019-04-01       Impact factor: 3.603

2.  Association of oral toxicity and taste changes during hematopoietic stem cell transplantation: a preliminary study.

Authors:  Mariana Henriques Ferreira; Leticia Mello Bezinelli; Fernanda de Paula Eduardo; Roberta Marques Lopes; Andrea Z Pereira; Nelson Hamerschlack; Luciana Corrêa
Journal:  Support Care Cancer       Date:  2019-06-24       Impact factor: 3.603

3.  Chemosensory changes and quality of life in patients undergoing hematopoietic stem cell transplantation.

Authors:  Rania Abasaeed; Susan E Coldwell; Michele E Lloid; Sohaib H Soliman; Paula C Macris; Mark M Schubert
Journal:  Support Care Cancer       Date:  2018-04-27       Impact factor: 3.603

4.  Taste disorders following cancer treatment: report of a case series.

Authors:  Joel B Epstein; Safira Marques de Andrade E Silva; Geena L Epstein; Jorge Henrique Santos Leal; Andrei Barasch; Gregory Smutzer
Journal:  Support Care Cancer       Date:  2019-03-29       Impact factor: 3.603

5.  Oral health in allogeneic hematopoietic stem cells transplantation survivors.

Authors:  Paolo J Fantozzi; Nathaniel S Treister; Corey S Cutler; Alessandro Villa
Journal:  Bone Marrow Transplant       Date:  2020-05-07       Impact factor: 5.483

6.  Evaluation of the risk factors associated with high-dose chemotherapy-induced dysgeusia in patients undergoing autologous hematopoietic stem cell transplantation: possible usefulness of cryotherapy in dysgeusia prevention.

Authors:  Naoto Okada; Takeshi Hanafusa; Shinji Abe; Chiemi Sato; Toshimi Nakamura; Kazuhiko Teraoka; Masahiro Abe; Kazuyoshi Kawazoe; Keisuke Ishizawa
Journal:  Support Care Cancer       Date:  2016-04-29       Impact factor: 3.603

7.  Nutritional intake and nutritional status by the type of hematopoietic stem cell transplantation.

Authors:  Eun Jin So; Ji Sun Lee; Jee Yeon Kim
Journal:  Clin Nutr Res       Date:  2012-07-26

Review 8.  Oral Graft-Versus-Host Disease: A Pictorial Review and a Guide for Dental Practitioners.

Authors:  Sharon Elad; Omar Aljitawi; Yehuda Zadik
Journal:  Int Dent J       Date:  2021-01-12       Impact factor: 2.607

9.  Early and late oral features of chronic graft-versus-host disease.

Authors:  Alessandra Oliveira Ferrari Gomes; Sandra Regina Torres; Angelo Maiolino; Cesar Werneck Noce Dos Santos; Arley Silva Junior; Maria Elvira Pizzigatti Correa; Maria Cláudia Rodrigues Moreira; Lucio de Souza Gonçalves
Journal:  Rev Bras Hematol Hemoter       Date:  2014

10.  Oral features of graft-versus-host disease.

Authors:  Sandra Regina Torres
Journal:  Rev Bras Hematol Hemoter       Date:  2014
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.